 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Effects of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination on the Atherosclerosis-Related Process in a Type 2 Diabetes Mouse Model |
| Jin Hee Kim, Gha Young Lee, Hyo Jin Maeng, Hoyoun Kim, Jae Hyun Bae, Kyoung Min Kim, Soo Lim |
|
Endocrinol Metab. 2021;36(1):157-170. Published online February 24, 2021 DOI: https://doi.org/10.3803/EnM.2020.781 |
|
Effects of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination on the Atherosclerosis-Related Process in a Type 2 Diabetes Mouse Model Endocrinology and Metabolism. 2021;36(1):157-170  Unlocking the Therapeutic Potential of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination for the Pathogenesis of Atherosclerosis in Type 2 Diabetes Endocrinology and Metabolism. 2021;36(1):57-59 Diabetes and obesity. The role of agonists glucagon-like peptide-1 of in the treatment of type 2 diabetes Diabetes mellitus. 2018;21(4):293-300 Potential therapies mimicking the effects of glucagon-like peptide-1 for the treatment of Type 2 diabetes Diabetic Medicine. 2004;21(s1):18-20 Cardiovascular effects of glucagon-like peptide-1 receptor agonist therapies in patients with type 1 diabetes Diabetes, Obesity and Metabolism. 2017;19(5):613-614 Glucagon-like Peptide-1 Analogue and Dipeptidyl Peptidase-IV Inhibitors Journal of Korean Endocrine Society. 2006;21(6):437 Emerging incretin (glucagon-like peptide-1)-derived therapies for type 2 diabetes Diabetes, Obesity and Metabolism. 2008;10:1-1 Glucagon-like peptide-1 in type 2 diabetes: the -cell and beyond Diabetes, Obesity and Metabolism. 2008;10:2-13 Effects of body weight reduction on plasma fibroblast growth factor 21 in obese patients with type 1 diabetes mellitus Atherosclerosis. 2015;241(1):e178-e179 Effect of Fibroblast Growth Factor 21 on the Development of Atheromatous Plaque and Lipid Metabolic Profiles in an Atherosclerosis-Prone Mouse Model International Journal of Molecular Sciences. 2020;21(18):6836 |
